The immuno-inflammatory response to trauma

Abstract

The systemic inflammatory response syndrome is a well recognized physiological entity being part of our homeostatic mechanisms. It represents the cascade of inflammatory reactions initiated in the immediate aftermath following trauma reflecting the state of alertness that our body undergoes in order to fight for survival. A variety of inflammatory mediators and cellular elements are involved during this process interacting amongst each other. This allows communication between the different organ systems and thus regulating local and systemic responses. We have just begun to characterize and quantify the immuno-inflammatory response to trauma and this has opened new horizons in the way we understand the pathophysiological response to injury. As our knowledge evolves new therapeutic agents and innovative treatment plans will be developed contributing to increased survival rates in patients with multiple injuries.

Keywords

DCO immuno-inflammatory response second hit SIRS trauma

Get full access to this article

View all access options for this article.

References

Acute Respiratory Distress Syndrome Network . 2000. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. New England Journal of Medicine 342: 1301-1308.

Anderson BO , Harken AH. 1990. Multiple organ failure: inflammatory priming and activation sequences promote autologous tissue injury. J Trauma 30(12 Suppl): S44-S49.

Baldwin SR , Simon RH , Grum CM et al. 1986. Oxidant activity in expired breath of patients with the adult respiratory distress syndrome. Lancet 4: 11-14.

Bernard GR , Wheeler AP , Arons MM et al. 1997. A trial of antioxidants N-acetylcysteine and procysteine in ARDS. The Antioxidant in ARDS Study Group. Chest 112: 164-172.

Bernard GR , Vincent JL , Laterre PF. 2001. Efficacy and safety of recombinant human activated protein C for severe sepsis. New England Journal of Medicine 344: 699-709.

Bernhagen J , Calandra T , Bucala R. 1998. Regulation of the immune response by macrophage migration inhibitory factor: biological and structural features. Journal of Molecular Medicine 76: 151-161.

Bone RC. 1996. Toward a theory regarding the pathogenesis of the systemic inflammatory reponse syndrome: what we do and do not know about cytokine regulation. Crit Care Med 24: 162-172.

Bone LB , Johnson KD , Weigelt J , Scheinberg R. 1989. Early versus delayed stabilization of fractures. A prospective randomized study. J Bone Joint Surg 71A: 336-340.

Bone RC , Balk RA , Cerra FB , et al. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101: 1644-1655.

10.

Bozza M , Bliss JL , Dorner AJ , Trepicchio WL. 2001. Interleukin-11 modulates Th1/Th2 cytokine production from activated CD4+ T cells. J Interf Cytok Res 21: 21-30.

11.

Brand JM , Frohn C , Luhm J et al. 2003. Early alterations in the number of circulating lymphocyte subpopulations and enhanced proinflammtory immune response during opioid-based general anaesthesia. Shock 20: 213-217.

12.

Broze GJ. 2003. The rediscovery and isolation of TFPI. J Throm Haem 1: 1671-1675.

13.

Bowcock AM , Ray A , Erlich H , Sehgal PB. 1989. Rapid detection and sequencing of alleles in the 3′ flanking region of the interleukin-6 gene. Nucleic Acids Res 17: 6855-6864.

14.

Carey PD , Leeper-Wodford SK , Walsh CJ et al. 1991. Delayed cyclooxygenase blockade reduces the neutrophil respiratory burst and tumour necrosis factor levels in sepsis induced acute lung injury. J Trauma 31: 733-741.

15.

Cipolle MD , Pasquale MD , Cerra FB. 1993. Secondary organ dysfunction. From clinical perspectives to molecular mediators. Crit Care Clin 9: 261-298.

16.

Clemenza L , Dieli F , Cicardi M et al. 2003. Research on complement: old issues revisited and a novel sphere of influence. Trends Immunol 24: 292-296.

17.

Cole DS , Morgan BP. 2003. Beyond lysis: how complement influences cell fate. Clin Sci 104: 455-466.

18.

Davis EG , Eichenberger MR , Grant BS , Polk HC Jr. 2000. Microsatellite marker of interferon-gamma receptor 1 gene correlates with infection following major trauma. Surgery 128: 301-305.

19.

Dhainaut JF , Laterre PF , Janes JM et al. 2003. Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial. Intens Care Med 29: 894-899.

20.

dos Santos CC , Chant C , Slutsky AS. 2002. Pharmacotherapy of acute respiratory distress syndrome. Expert Opin Pharmaco 3: 875-888.

21.

Eisman B , Beart R , Norton L. 1977. Multiple organ failure. Surg Gynaecol Obstet 144: 323-325.

22.

El Azab SR , Rossel PM , DeLange JJ et al. 2002. Effect of VIMA with sevoflurane versus TIVA with propofol or midazolam-sufentanil on the cytokine response during CABG surgery. Eur J Anaesth 9: 276-282.

23.

Ely EW , Laterre PF , Angus DC et al. 2003. Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis. Crit Care Med 31: 12-19.

24.

Ertel W , Keel M , Bonaccio M et al. 1995. Release of anti-inflammatory mediators after mechanical trauma correlates with severity of injury and clinical outcome. J Trauma 39: 879-887.

25.

Esmon CT. 2003. The protein C pathway. Chest 124: 26S-32S.

26.

Fishelson Z. 1991. Complement C3: a molecular mosaic of binding sites. Mol Immunol 28: 545-552.

27.

Fishman D , Faulds G , Jeffery R et al. 1998. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102: 1369-1376.

28.

Froidevaux C , Roger T , Martin C et al. 2001. Macrophage migration inhibitory factor and innate immune responses to bacterial infections. Crit Care Med 29: S13-S15.

29.

Fry DE , Pearlstein L , Fulton RL , Polk HC Jr. 1980. Multiple system organ failure. The role of uncontrolled infection. Arch Surg 115: 136-214.

30.

Giannoudis PV , Pape HC , Cohen AP et al. 2002. Review: systemic effects of femoral nailing: from Kuntscher to the immune reactivity era. Clin Orthop Relat Res 404: 378-386.

31.

Giannoudis PV , Smith PM , Ramsden CW et al. 1996. Molecular mediators and trauma: effects of accidental trauma on the production of plasma elastase, IL-6, ICAM-1 and sE-selectin. Injury 27: 376-377.

32.

Giannoudis PV , Abbott C , Stone M et al. 1998a. Fatal systemic inflammatory response syndrome following early bilateral femoral nailing. Intens Care Med 24: 641-642.

33.

Giannoudis PV , Smith RM , Banks RE et al. 1998b. Stimulation of inflammatory markers after blunt trauma. Br J Surg 85: 986-990.

34.

Giannoudis PV , Smith RM , Bellamy MC et al. 1999a. Stimulation of the inflammatory system by reamed and unreamed nailing of femoral fractures. An analysis of the second hit. J Bone Joint Surg Br 81: 356-361.

35.

Giannoudis PV , Smith RM , Windsor AC et al. 1999b. Monocyte human leukocyte antigen-DR expression correlates with intrapulmonary shunting after major trauma. Am J Surg 177: 454-459.

36.

Giannoudis PV , Smith MR , Evans RT et al. 1998c. Serum CRP and IL-6 levels after trauma. Not predictive of septic complications in 31 patients. Acta Orthop Scand 69: 184-188.

37.

Giannoudis PV , Smith RM , Perry SL et al. 2000. Immediate IL-10 expression following major orthopaedic trauma: relationship to anti-inflammatory response and subsequent development of sepsis. Intens Care Med 26: 1076-1081.

38.

Goris JA , Boekhoerst TP , Nuytinck JK , Gimbrere JS. 1985. Multiple organ failure. Arch Surg 120: 1109-1115

39.

Granger DN , Kubes P. 1994. The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J Leukoc Biol 55: 662-675.

40.

Guillou PJ. 1993. Biological variation in the development of sepsis after surgery or trauma. Lancet 342: 217-220.

41.

Haddad JJ , Saade NE , Safieh-Garabedian B. 2002. Cytokines and neuro-immune-endocrine interactions: a role for the hypothalamic-pituitary-adrenal revolving axis. J Neuroimmunol 133: 1-19.

42.

Harlan JM. 1987. Neutrophil-mediated vascular injury. Acta Med Scand 715(Suppl): 123-129.

43.

Hauser CJ , Zhou X , Joshi P et al. 1997. The immune microenviroment of human fracture/soft-tissue hematomas and its relationship to systemic immunity. J Trauma 42: 895-903.

44.

Hoch RC , Rodriguez R , Manning T et al. 1993. Effects of accidental trauma on cytokine and endotoxin production. Crit Care Med 21: 839-845.

45.

Jouanguy E , Altare F , Lamhamedi S et al. 1996. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette Guerin infection. N Engl J Med 335: 1956-1961.

46.

Keel M , Schregenberger N , Steckholzer U et al. 1996. Endotoxin tolerance after severe injury and its regulatory mechanisms. J Trauma 41: 430-438.

47.

Keh D , Boehnke T , Weber-Cartens S et al. 2003. Immunologic and hemodynamic effects of ‘low-dose’ hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Resp Crit Care Med 167: 512-520.

48.

Levy MM , Fink MP , Marshall JC et al. 2003. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31: 1250-1256.

49.

Lim YP , Bendelja K , Opal SM et al. 2003. Correlation between mortality and the levels of inter-alpha inhibitors in the plasma of patients with severe sepsis. J Infect Dis 188: 919-926.

50.

Maekawa K , Futami S , Nishida M et al. 1998. Effects of trauma and sepsis on soluble L-selectin and cell surface expression of L-selectin and CD11b. J Trauma 44: 460-468.

51.

Meakins JL , Pietsch JB , Bubenick O et al. 1977. Delayed hypersensitivity: indicator of acquired failure of host defenses in sepsis and trauma. Ann Surg 186: 241-250.

52.

Meduri GU , Headley AS , Golden E et al. 1998. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 280: 159-165.

53.

Messori A , Vacca F , Vaiani M et al. 2002. Antithrombin III in patients admitted to intensive care units: a multicenter observational study. Crit Care 6: 447-451.

54.

Mira JP , Cariou A , Grall F et al. 1999. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 282: 561-568.

55.

Napolitano LM , Ferrer T , McCarter RJ Jr , Scalea TM. 2000. Systemic inflammatory response syndrome score at admission independently predicts mortality and length of stay in trauma patients. J Trauma 49: 647-653.

56.

Newport MJ , Huxley CM , Huston S et al. 1996. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 335: 1941-1949.

57.

Norton LW. 1985. Does drainage of intra-abdominal pus reverse multiple organ failure? Am J Surg 149: 347-350.

58.

Obertacke U , Kleinschmidt C , Dresing K et al. 1993. Repeated routine determination of pulmonary microvascular permeability after polytrauma. Unfallchirurg 96: 142-149. [In German].

59.

O’Keefe GE , Hybki DL , Munford RS. 2002. The G—A single nucleotide polymorphism at the — 308 position in the tumor necrosis factor-alpha promoter increases the risk for severe sepsis after trauma. J Trauma 52: 817-826.

60.

Olson SA. 2004. Pulmonary aspects of treatment of long bone fractures in the polytrauma patient. Clin Orthop 422: 66-70.

61.

Osiri M , McNicholl J , Moreland LW , Bridges SL Jr. 1999. A novel single nucleotide polymorphism and five probable haplotypes in the 5¢ flanking region of the IL-6 gene in African-Americans. Genes Immun 1: 166-167.

62.

Pangburn MK , Rawal N. 2002. Structure and function of complement C5 convertase enzymes. Biochem Soc Trans 30: 6-10.

63.

Pape HC , Auf’m’Kolk M , Paffrath T et al. 1993. Primary intramedullary femur fixation in multiple trauma patients with associated lung contusion - a cause of posttraumatic ARDS? J Trauma 34: 540-548.

64.

Pape HC , Grimme K , Van Griensven M et al. 2003. EPOFF Study Group. Impact of intramedullary instrumentation versus damage control for femoral fractures on immuno-inflammatory parameters: prospective randomized analysis by the EPOFF Study Group. J Trauma 55: 7-13.

65.

Pape HC , Schmidt RE , Rice J et al. 2000. Biochemical changes after trauma and skeletal surgery of the lower extremity: quantification of the operative burden. Crit Care Med 28: 3441-3448.

66.

Pape HC , Tscherne H. 2000. Early definitive fracture fixation, pulmonary function and systemic effects. In: Baue AE , Faist E , Fry M eds. Multiple organ failure.New York: Springer, 279-290.

67.

Pape HC , van Griensven M , Rice J et al. 2001. Major secondary surgery in blunt trauma patients and perioperative cytokine liberation: determination of the clinical relevance of biochemical markers. J Trauma 50: 989-1000.

68.

Pawlinski R , Pedersen B , Kehrle B et al. 2003. Regulation of tissue factor and inflammatory mediators by Egr-1 in a mouse endotoxemia model. Blood 101: 3940-3947.

69.

Polk HC Jr. 1987. Non-specific host defence stimulation in the reduction of surgical infection in man. Br J Surg 74: 969-970.

70.

Ranieri VM , Suter PM , Tortorella C et al. 1999. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial [comment]. JAMA 282: 54-61.

71.

Riedemann NC , Guo RF , Ward PA. 2003. Novel strategies for the treatment of sepsis. Nature Medicine 9: 517-524.

72.

Riewald M , Ruf W. 2003. Science review: role of coagulation protease cascades in sepsis. Critical Care 7: 123-129.

73.

Rivkind AI , Siegel JH , Lettleton M et al. 1991. Neutrophil oxidative burst activation and the pattern of respiratory physiologic abnormalities in the fulminant post-traumatic adult respiratory distress syndrome. Circ Shock 33: 48-62.

74.

Rotstein OD. 2003. Modeling the two-hit hypothesis for evaluating strategies to prevent organ injury after shock/resuscitation. J Trauma 54(5 Suppl): S203-S206.

75.

Salmon JE , Edberg JC , Brogle NL , Kimberly RP. 1992. Allelic polymorphisms of human Fc gamma receptor IIA and Fc gamma receptor IIIB. Independent mechanisms for differences in human phagocyte function. J Clin Invest 89: 1274-1281.

76.

Sauaia A , Moore FA , Moore EE et al. 1995. Epidemiology of trauma deaths: a reassessment. J Trauma 38: 185-193.

77.

Schneemilch CE , Bank U. 2001. Release of pro- and anti-inflammatory cytokines during different anesthesia procedures. Anaesthesiologie and Reanimation 26: 4-10.

78.

Seibel R , LaDuca J , Hassett JM et al. 1985. Blunt multiple trauma (ISS 36), femur traction and the pulmonary failure septic state. Ann Surg 283: 202-203.

79.

Shapiro MB , Jenkins DH , Schwab CW , Rotondo MF. 2000. Damage control: collective review. J Trauma 49: 969-978.

80.

Shields CJ , Sookhai S , Winter DC et al. 2002. Attenuation of pancreatitis induced pulmonary injury by aerosolized hypertonic saline. Surg Infect 2: 215-224.

81.

Smith RM , Giannoudis PV. 1998. Trauma and the immune response. J R Soc Med 91: 417-420.

82.

Smith RM , Giannoudis PV , Bellamy MC et al. 2000. Interleukin-10 release and monocyte human leukocyte antigen-DR expression during femoral nailing. Clin Orthop 373: 233-240.

83.

Stüber F , Petersen M , Bokelmann F , Schade U. 1996. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Crit Care Med 24: 381-384.

84.

Tan LR , Waxman K , Scannell G et al. 1993. Trauma causes early release of soluble receptors for tumor necrosis factor. J Trauma 34: 634-638.

85.

Tilney NL , Bailey GL , Morgan AP. 1973. Sequential system failure after rupture of abdominal aortic aneurysms: an unsolved problem in post-operative care. Ann Surg 178: 117-122.

86.

Vincent JL , Angus DC , Artigas A et al. 2003. Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial. Crit Care Med 31: 834-840.

87.

Vodovotz Y , Clermont G , Chow C et al. 2004. Mathematical models of the acute inflammatory response. Curr Opin Crit Care 10: 383-390.

88.

Walsh CJ , Carey PD , Cook DJ et al. 1991. Anti-CD18 antibody attenuates neutropenia and alveolar capillary-membrane injury during gram-negative sepsis. Surgery 110: 205-211.

89.

Waydhas C , Nast-Kolb D , Trupka A et al. 1996. Posttraumatic inflammatory response, secondary operations, and late multiple organ failure. J Trauma 40: 624-631.

90.

Weigand MA , Schmidt H , Pourmahmoud M et al. 1999. Circulating intracellular adhesion molecule-1 as an early predictor of hepatic failure in patients with septic shock. Crit Care Med 27: 2656-2661.

91.

Yuksel M , Okajima K , Uchiba M et al. 2002. Activated protein C inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production by inhibiting activation of both nuclear factor-kappa B and activator protein-1 in human monocytes. Thromb Haemostasis 88: 267-273.

92.

Zheutlin LM , Thonor EJ , Jacobs ER. 1986. Plasma elastase levels in the adult respiratory distress syndrome. Crit Care Med 1: 39-44.